CN Stock MarketDetailed Quotes

300841 Chengdu Kanghua Biological Products

Watchlist
  • 48.09
  • -1.48-2.99%
Market Closed Sep 6 15:00 CST
6.48BMarket Cap11.41P/E (TTM)

Chengdu Kanghua Biological Products Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
16.81%741.08M
11.96%311.37M
9.03%1.58B
-6.12%990.06M
-3.84%634.44M
4.27%278.11M
11.94%1.45B
35.23%1.05B
19.53%659.77M
12.48%266.74M
Operating revenue
16.81%741.08M
11.96%311.37M
9.03%1.58B
-6.12%990.06M
-3.84%634.44M
4.27%278.11M
11.94%1.45B
35.23%1.05B
19.53%659.77M
12.48%266.74M
Other operating revenue
3,747,465.37%106.24M
----
-99.11%2.84K
----
--2.84K
----
--318.58K
----
--0
----
Total operating cost
0.60%365.39M
-19.05%134.86M
22.80%959.26M
15.87%586.25M
22.16%363.21M
38.63%166.6M
20.72%781.12M
38.27%505.94M
14.61%297.32M
2.99%120.17M
Operating cost
-1.62%40.45M
-27.99%12.93M
9.68%102.15M
-4.57%63.76M
2.43%41.12M
15.80%17.96M
11.21%93.13M
30.08%66.82M
14.12%40.14M
-1.88%15.51M
Operating tax surcharges
17.39%5.26M
26.47%1.43M
18.61%9.76M
2.94%5.9M
9.20%4.48M
0.94%1.13M
15.33%8.23M
39.12%5.73M
28.05%4.1M
17.52%1.12M
Operating expense
18.24%207.05M
-8.28%71.89M
15.73%495.44M
4.95%270.26M
14.18%175.11M
14.13%78.39M
3.89%428.12M
18.06%257.51M
-0.83%153.37M
6.21%68.68M
Administration expense
33.72%54.11M
12.59%24.97M
29.22%106.82M
14.31%66.26M
2.19%40.46M
15.89%22.18M
-4.27%82.66M
-7.83%57.96M
-9.85%39.6M
-20.26%19.14M
Financial expense
-59.14%-6M
-28.00%-2.2M
27.55%-7.95M
40.27%-5.86M
53.37%-3.77M
67.47%-1.72M
48.11%-10.97M
39.97%-9.82M
32.38%-8.08M
3.68%-5.29M
-Interest expense (Financial expense)
13.30%2.67M
37.51%1.41M
50.71%4.81M
76.90%3.54M
184.89%2.36M
1,441.19%1.02M
4,286.84%3.19M
3,316.43%2M
1,816.19%826.91K
--66.49K
-Interest Income (Financial expense)
-17.00%-6.94M
-24.89%-3.46M
11.68%-12.59M
22.04%-9.24M
34.03%-5.93M
48.46%-2.77M
33.01%-14.26M
28.01%-11.86M
25.34%-9M
2.31%-5.37M
Research and development
-39.02%64.53M
-46.92%25.83M
40.62%253.03M
45.56%185.93M
55.17%105.81M
131.58%48.66M
128.13%179.94M
179.06%127.73M
98.05%68.19M
25.42%21.01M
Credit Impairment Loss
-117.30%-22.07M
26.98%-5.56M
72.19%-9.84M
63.68%-7.28M
44.77%-10.16M
-116.24%-7.61M
-317.30%-35.37M
-218.59%-20.03M
-363.16%-18.39M
-25.83%-3.52M
Asset Impairment Loss
129.91%139.17K
151.32%94.42K
81.27%-1.63M
236.90%1.29M
46.41%-465.23K
71.78%-183.96K
-345.37%-8.71M
-3.45%-944.55K
-46.55%-868.06K
-182.28%-651.8K
Other net revenue
-452.04%-24.28M
-178.90%-4.36M
-308.64%-41.52M
102.28%4.72M
948.03%6.9M
-42.30%5.52M
-92.64%19.9M
-99.02%2.33M
-113.25%-813.22K
740.54%9.57M
Fair value change income
-129.64%-4.58M
-96.00%521.7K
-160.89%-31.6M
-6.44%10.94M
62.00%15.44M
4.10%13.05M
-80.73%51.89M
-95.09%11.7M
24.75%9.53M
--12.54M
Invest income
--800.42K
--91.66K
-93.04%348.75K
----
----
----
7.68%5.01M
23.35%5.01M
77.93%5.01M
----
Asset deal income
----
----
---186.83K
----
----
----
----
----
----
----
Other revenue
-31.00%1.43M
88.31%491.51K
-80.51%1.38M
-103.70%-244.09K
-46.85%2.08M
-78.27%261.01K
3.91%7.08M
248.06%6.6M
1,487.07%3.91M
967.30%1.2M
Operating profit
26.35%351.41M
47.09%172.15M
-15.88%576.61M
-25.85%408.53M
-23.09%278.12M
-25.04%117.04M
-25.14%685.5M
-15.36%550.94M
21.07%361.64M
31.24%156.13M
Add:Non operating Income
----
----
-87.34%15.5K
-63.85%44.07K
208.45%15.43K
729,894.63%10.88K
-70.91%122.45K
-71.04%121.92K
109.06%5K
-99.94%1.49
Less:Non operating expense
-53.95%111.46K
-93.32%10.68K
43.83%2.63M
-54.49%539.07K
-78.56%242.03K
98,293.32%159.84K
205.41%1.83M
106.53%1.18M
134.82%1.13M
-97.48%162.45
Total profit
26.42%351.3M
47.27%172.14M
-16.06%573.99M
-25.80%408.03M
-22.92%277.9M
-25.14%116.89M
-25.32%683.79M
-15.50%549.87M
20.89%360.52M
31.25%156.13M
Less:Income tax cost
50.71%44.75M
93.85%22.68M
-24.44%64.78M
-41.27%39.09M
-33.79%29.69M
-43.91%11.7M
-0.43%85.73M
-1.24%66.56M
-2.63%44.84M
12.96%20.86M
Net profit
23.51%306.55M
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
34.60%135.28M
Net profit from continuing operation
----
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
----
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
----
34.60%135.28M
Net profit of parent company owners
23.51%306.55M
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
34.60%135.28M
Earning per share
Basic earning per share
24.20%2.3049
42.45%1.1204
-14.73%3.8073
-23.52%2.7584
-21.17%1.8558
-21.94%0.7865
-27.56%4.4652
-16.79%3.6067
25.65%2.3542
-9.77%1.0076
Diluted earning per share
24.23%2.3049
42.49%1.1204
-14.71%3.8073
-23.53%2.758
-21.19%1.8554
-21.96%0.7863
-27.57%4.464
-16.79%3.6067
25.65%2.3542
-9.78%1.0075
Other composite income
Total composite income
23.51%306.55M
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
34.60%135.28M
Total composite income of parent company owners
23.51%306.55M
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
34.60%135.28M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 16.81%741.08M11.96%311.37M9.03%1.58B-6.12%990.06M-3.84%634.44M4.27%278.11M11.94%1.45B35.23%1.05B19.53%659.77M12.48%266.74M
Operating revenue 16.81%741.08M11.96%311.37M9.03%1.58B-6.12%990.06M-3.84%634.44M4.27%278.11M11.94%1.45B35.23%1.05B19.53%659.77M12.48%266.74M
Other operating revenue 3,747,465.37%106.24M-----99.11%2.84K------2.84K------318.58K------0----
Total operating cost 0.60%365.39M-19.05%134.86M22.80%959.26M15.87%586.25M22.16%363.21M38.63%166.6M20.72%781.12M38.27%505.94M14.61%297.32M2.99%120.17M
Operating cost -1.62%40.45M-27.99%12.93M9.68%102.15M-4.57%63.76M2.43%41.12M15.80%17.96M11.21%93.13M30.08%66.82M14.12%40.14M-1.88%15.51M
Operating tax surcharges 17.39%5.26M26.47%1.43M18.61%9.76M2.94%5.9M9.20%4.48M0.94%1.13M15.33%8.23M39.12%5.73M28.05%4.1M17.52%1.12M
Operating expense 18.24%207.05M-8.28%71.89M15.73%495.44M4.95%270.26M14.18%175.11M14.13%78.39M3.89%428.12M18.06%257.51M-0.83%153.37M6.21%68.68M
Administration expense 33.72%54.11M12.59%24.97M29.22%106.82M14.31%66.26M2.19%40.46M15.89%22.18M-4.27%82.66M-7.83%57.96M-9.85%39.6M-20.26%19.14M
Financial expense -59.14%-6M-28.00%-2.2M27.55%-7.95M40.27%-5.86M53.37%-3.77M67.47%-1.72M48.11%-10.97M39.97%-9.82M32.38%-8.08M3.68%-5.29M
-Interest expense (Financial expense) 13.30%2.67M37.51%1.41M50.71%4.81M76.90%3.54M184.89%2.36M1,441.19%1.02M4,286.84%3.19M3,316.43%2M1,816.19%826.91K--66.49K
-Interest Income (Financial expense) -17.00%-6.94M-24.89%-3.46M11.68%-12.59M22.04%-9.24M34.03%-5.93M48.46%-2.77M33.01%-14.26M28.01%-11.86M25.34%-9M2.31%-5.37M
Research and development -39.02%64.53M-46.92%25.83M40.62%253.03M45.56%185.93M55.17%105.81M131.58%48.66M128.13%179.94M179.06%127.73M98.05%68.19M25.42%21.01M
Credit Impairment Loss -117.30%-22.07M26.98%-5.56M72.19%-9.84M63.68%-7.28M44.77%-10.16M-116.24%-7.61M-317.30%-35.37M-218.59%-20.03M-363.16%-18.39M-25.83%-3.52M
Asset Impairment Loss 129.91%139.17K151.32%94.42K81.27%-1.63M236.90%1.29M46.41%-465.23K71.78%-183.96K-345.37%-8.71M-3.45%-944.55K-46.55%-868.06K-182.28%-651.8K
Other net revenue -452.04%-24.28M-178.90%-4.36M-308.64%-41.52M102.28%4.72M948.03%6.9M-42.30%5.52M-92.64%19.9M-99.02%2.33M-113.25%-813.22K740.54%9.57M
Fair value change income -129.64%-4.58M-96.00%521.7K-160.89%-31.6M-6.44%10.94M62.00%15.44M4.10%13.05M-80.73%51.89M-95.09%11.7M24.75%9.53M--12.54M
Invest income --800.42K--91.66K-93.04%348.75K------------7.68%5.01M23.35%5.01M77.93%5.01M----
Asset deal income -----------186.83K----------------------------
Other revenue -31.00%1.43M88.31%491.51K-80.51%1.38M-103.70%-244.09K-46.85%2.08M-78.27%261.01K3.91%7.08M248.06%6.6M1,487.07%3.91M967.30%1.2M
Operating profit 26.35%351.41M47.09%172.15M-15.88%576.61M-25.85%408.53M-23.09%278.12M-25.04%117.04M-25.14%685.5M-15.36%550.94M21.07%361.64M31.24%156.13M
Add:Non operating Income ---------87.34%15.5K-63.85%44.07K208.45%15.43K729,894.63%10.88K-70.91%122.45K-71.04%121.92K109.06%5K-99.94%1.49
Less:Non operating expense -53.95%111.46K-93.32%10.68K43.83%2.63M-54.49%539.07K-78.56%242.03K98,293.32%159.84K205.41%1.83M106.53%1.18M134.82%1.13M-97.48%162.45
Total profit 26.42%351.3M47.27%172.14M-16.06%573.99M-25.80%408.03M-22.92%277.9M-25.14%116.89M-25.32%683.79M-15.50%549.87M20.89%360.52M31.25%156.13M
Less:Income tax cost 50.71%44.75M93.85%22.68M-24.44%64.78M-41.27%39.09M-33.79%29.69M-43.91%11.7M-0.43%85.73M-1.24%66.56M-2.63%44.84M12.96%20.86M
Net profit 23.51%306.55M42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M34.60%135.28M
Net profit from continuing operation ----42.09%149.47M-14.86%509.22M-23.66%368.94M-----22.24%105.19M-27.90%598.07M-17.15%483.31M----34.60%135.28M
Net profit of parent company owners 23.51%306.55M42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M34.60%135.28M
Earning per share
Basic earning per share 24.20%2.304942.45%1.1204-14.73%3.8073-23.52%2.7584-21.17%1.8558-21.94%0.7865-27.56%4.4652-16.79%3.606725.65%2.3542-9.77%1.0076
Diluted earning per share 24.23%2.304942.49%1.1204-14.71%3.8073-23.53%2.758-21.19%1.8554-21.96%0.7863-27.57%4.464-16.79%3.606725.65%2.3542-9.78%1.0075
Other composite income
Total composite income 23.51%306.55M42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M34.60%135.28M
Total composite income of parent company owners 23.51%306.55M42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M34.60%135.28M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg